Science, journalists and big pharma
The Air Force/Texas Cornornary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) looked at 6,600 generally healthy middle-aged people who did not have elevated LDL (”bad cholesterol”). It was a standard randomized double-blind trial comparing lovastatin with placebo. Patients were followed for an average of just over 5 years. It suggested that lovastatin could help to prevent coronary heart […]